Back to Market Feed

Product Information

NEOMYC-BACIT-POLYMIX EYE OINT is a generic product labeled by Bausch & Lomb Incorporated, priced at $4.6329 per GM under NDC 24208078055. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Oct 30, 1995. Its Orange Book therapeutic-equivalence code is AT.

NEOMYC-BACIT-POLYMIX EYE OINT

Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc
$4.6329per GM

Strength

400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g

NDC

24208078055

Classification

Generic

Dosage Form

OINTMENT

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA064064

FDA Approved

10/30/1995

TE Code

AT

On Market Since

10/30/1995

Pharmacological Classes

Aminoglycoside Antibacterial
Aminoglycosides
Decreased Cell Wall Synthesis & Repair
Polymyxin-class Antibacterial
Polymyxins

Price Statistics

The NADAC for NEOMYC-BACIT-POLYMIX EYE OINT has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 57.3%. The table below summarizes its recorded NADAC range and movement.

Current price$4.6329 per GM
All-time high$12.5571 (Feb 12, 2014)
All-time low$4.5062 (Jul 22, 2026)
52-week high$5.0029
52-week low$4.5062
Median price$7.6919
Average price$8.2715
Largest weekly change+69.1% (Nov 18, 2020)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+2.8%

1M

+2.8%

3M

-3.2%

6M

-2.6%

1Y

-1.9%

3Y

-28.0%

5Y

-49.6%

All

-57.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BACITRACIN 500 UNIT/GM OINTMNT
Generic
00536125628•Rugby Laboratories
$0.0539
per GM
BACITRACIN 500 UNIT/GM OINTMNT
Generic
00713028031•Cosette Pharmaceuticals, Inc.
$0.0740
per GM
BACITRACIN 500 UNIT/GM OINTMNT
Generic
68001047747•BluePoint Laboratories
$0.0740
per GM
BACITRACIN 500 UNIT/GM OINTMNT
Generic
45802006003•Padagis Israel Pharmaceuticals Ltd
$0.0758
per GM
BACITRACIN ZN 500 UNIT/GM OINT
Generic
36800008902•Topco Associates LLC
$0.0761
per GM
BACITRACIN ZN 500 UNIT/GM OINT
Generic
00536126328•Rugby Laboratories
$0.0785
per GM
BACITRACIN ZN 500 UNIT/GM OINT
Generic
70000054701•Cardinal Health
$0.0785
per GM
GS FIRST AID ANTIBIOTIC OINT
Generic
00113008464•L. Perrigo Company
$0.0886
per GM
TRIPLE ANTIBIOTIC OINTMENT
Generic
00904880531•Major Pharmaceuticals
$0.0886
per GM
TRIPLE ANTIBIOTIC OINTMENT
Generic
11527016255•Sheffield Pharmaceuticals LLC
$0.0886
per GM

Frequently asked questions

What is the NADAC price of NEOMYC-BACIT-POLYMIX EYE OINT?

The current National Average Drug Acquisition Cost (NADAC) for NEOMYC-BACIT-POLYMIX EYE OINT, manufactured by Bausch & Lomb Incorporated, is $4.6329 per GM (NDC 24208078055), effective Aug 19, 2026.

How has the price of NEOMYC-BACIT-POLYMIX EYE OINT changed over time?

Over the history we have for it, the NADAC for NEOMYC-BACIT-POLYMIX EYE OINT has declined 57.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NEOMYC-BACIT-POLYMIX EYE OINT?

Since Nov 28, 2013, the NADAC for NEOMYC-BACIT-POLYMIX EYE OINT has ranged from a low of $4.5062 (Jul 22, 2026) to a high of $12.5571 (Feb 12, 2014), with a median of $7.6919 per GM.

Are there cheaper alternatives to NEOMYC-BACIT-POLYMIX EYE OINT?

No other NADAC-published product currently shares the active ingredient and strength of NEOMYC-BACIT-POLYMIX EYE OINT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NEOMYC-BACIT-POLYMIX EYE OINT?

NEOMYC-BACIT-POLYMIX EYE OINT (NDC 24208078055) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.